Therapeutic Area Market Research Reports & Industry Analysis
Therapeutic areas include Cardiology/Vascular Diseases, Dental and Oral Health, Dermatology, Devices, Endocrinology, Family Medicine, Gastroenterology, Genetic Disease, Healthy Volunteers, Hematology, Hepatology, Immunology, Infections and Infectious Diseases, Internal Medicine, Musculoskeletal, Nephrology, Neurology, Nutrition and Weight Loss, Obstetrics/Gynecology, Oncology, Ophthalmology, Orthopedics/Orthopedic Surgery, Otolaryngology, Pediatrics/Neonatology, Pharmacology/Toxicology, Podiatry, Psychiatry/Psychology, Pulmonary/Respiratory Diseases, Rheumatology, Sleep, Trauma, Urology, and Vaccines.
Reports in these categories will contain statistics of prevalence and growth concerning therapeutic area diseases for which there are product reviews, market size, and share for products that are used in pharmaceutical treatment or equipment that used in surgical treatment of the therapeutic area.
Therapeutic Area Industry Research & Market Reports
-
Contract Research Organization Services (CROs)
... Billion by 2030, growing at a CAGR of 10.6% over the analysis period 2024-2030. Clinical Research Services, one of the segments analyzed in the report, is expected to record a 11.4% CAGR and reach US$76.7 ... Read More
-
CNS Therapeutics
... CAGR of 7.3% over the analysis period 2024-2030. Neurodegenerative Diseases Therapeutics, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$75.9 Billion by the end of the ... Read More
-
Bone Growth Stimulators
... at a CAGR of 4.9% over the analysis period 2024-2030. Stimulation Devices, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$855.7 Million by the end of ... Read More
-
Corporate Wellness
... CAGR of 6.5% over the analysis period 2024-2030. Health Risk Assessment, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$27.9 Billion by the end of the ... Read More
-
Contraceptives
... 6.3% over the analysis period 2024-2030. Contraceptive Drugs, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$26.0 Billion by the end of the analysis period. Growth ... Read More
-
Bioprosthetics
... 9.7% over the analysis period 2024-2030. Xenograft, one of the segments analyzed in the report, is expected to record a 10.2% CAGR and reach US$8.3 Billion by the end of the analysis period. Growth in ... Read More
-
Cancer Immunotherapy
... CAGR of 13.7% over the analysis period 2024-2030. Monoclonal Antibodies, one of the segments analyzed in the report, is expected to record a 14.5% CAGR and reach US$266.2 Billion by the end of the analysis ... Read More
-
Cancer Stem Cells
... at a CAGR of 8.5% over the analysis period 2024-2030. Stem Cell-based Cancer Therapy, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$1.3 Billion by the ... Read More
-
End-Stage Renal Disease
... at a CAGR of 11.7% over the analysis period 2024-2030. Hemodialysis Treatment, one of the segments analyzed in the report, is expected to record a 12.9% CAGR and reach US$209.9 Billion by the end of ... Read More
-
Intracranial Aneurysm
... CAGR of 8.7% over the analysis period 2024-2030. Endovascular Coiling, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$2.3 Billion by the end of the analysis ... Read More
-
Oncology Based In-Vivo CRO
... 2030, growing at a CAGR of 7.0% over the analysis period 2024-2030. Solid Tumors Indication, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$1.2 Billion by ... Read More
-
Artificial Tendons and Ligaments
... 2030, growing at a CAGR of 10.6% over the analysis period 2024-2030. Knee Injuries Application, one of the segments analyzed in the report, is expected to record a 11.0% CAGR and reach US$35.2 Million by ... Read More
-
Cold, Cough, And Sore Throat Remedies
... reach US$9.7 Billion by 2030, growing at a CAGR of 5.2% over the analysis period 2024-2030. Syrups & Drops, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and ... Read More
-
Atrial Fibrillation Devices
... at a CAGR of 12.0% over the analysis period 2024-2030. EP Ablation Catheters, one of the segments analyzed in the report, is expected to record a 14.5% CAGR and reach US$4.8 Billion by the end ... Read More
-
Food Allergy and Intolerance Products
... Billion by 2030, growing at a CAGR of 6.0% over the analysis period 2024-2030. Lactose-Free Products, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$24.6 Billion ... Read More
-
Isosorbide - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
... forecast period 2024-2030. North American market for Isosorbide was valued at $ 30.30 million in 2023 and will reach $ 68.92 million by 2030, at a CAGR of 13.55% during the forecast period of 2024 ... Read More
-
Pedicle Screw System
... at a CAGR of 4.0% over the analysis period 2024-2030. Polyaxial Pedicle Screw System, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$1.6 Billion by the ... Read More
-
Pediatric Imaging
... CAGR of 7.1% over the analysis period 2024-2030. Magnetic Resonance Imaging, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$5.2 Billion by the end of the ... Read More
-
Retinal Implants
... CAGR of 7.1% over the analysis period 2024-2030. Implantable Miniature Telescope, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$34.4 Million by the end of the ... Read More
-
Scaffold Technology
... CAGR of 7.0% over the analysis period 2024-2030. Hydrogels, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$1.3 Billion by the end of the analysis period. ... Read More
-
Urology Surgical Instruments
... at a CAGR of 7.7% over the analysis period 2024-2030. Consumables & Accessories, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$13.5 Billion by the end ... Read More
-
Vaginitis Therapeutics
... CAGR of 7.6% over the analysis period 2024-2030. Anti-Bacterial Product, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$2.7 Billion by the end of the analysis ... Read More
-
Respiratory Protection Equipment
... at a CAGR of 6.4% over the analysis period 2024-2030. Air Purifying Respirators, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$15.3 Billion by the end ... Read More
-
Restorative Dentistry
... CAGR of 8.5% over the analysis period 2024-2030. Restorative Materials, one of the segments analyzed in the report, is expected to record a 9.6% CAGR and reach US$19.4 Billion by the end of the analysis ... Read More
-
Urothelial Cancer Drugs
... at a CAGR of 20.7% over the analysis period 2024-2030. Immunotherapy, one of the segments analyzed in the report, is expected to record a 20.3% CAGR and reach US$13.3 Billion by the end of the ... Read More
Research Assistance
